Cargando…
Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots
The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151019/ https://www.ncbi.nlm.nih.gov/pubmed/24722393 http://dx.doi.org/10.1038/clpt.2014.83 |
_version_ | 1782332986624049152 |
---|---|
author | Bosilkovska, M Samer, C F Déglon, J Rebsamen, M Staub, C Dayer, P Walder, B Desmeules, J A Daali, Y |
author_facet | Bosilkovska, M Samer, C F Déglon, J Rebsamen, M Staub, C Dayer, P Walder, B Desmeules, J A Daali, Y |
author_sort | Bosilkovska, M |
collection | PubMed |
description | The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B6), flurbiprofen (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), midazolam (CYP3A), and fexofenadine (P-gp) with coffee/Coke (CYP1A2) on four occasions. They received the cocktail alone (session 1), and with the CYP inhibitors fluvoxamine and voriconazole (session 2) and quinidine (session 3). In session 4, subjects received the cocktail after a 7-day pretreatment with the inducer rifampicin. The concentrations of probes/metabolites were determined in DBS and plasma using a single liquid chromatography–tandem mass spectrometry method. The pharmacokinetic profiles of the drugs were comparable in DBS and plasma. Important modulation of CYP and P-gp activities was observed in the presence of inhibitors and the inducer. Minimally invasive one- and three-point (at 2, 3, and 6 h) DBS-sampling methods were found to reliably reflect CYP and P-gp activities at each session. |
format | Online Article Text |
id | pubmed-4151019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-41510192014-09-04 Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots Bosilkovska, M Samer, C F Déglon, J Rebsamen, M Staub, C Dayer, P Walder, B Desmeules, J A Daali, Y Clin Pharmacol Ther Articles The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B6), flurbiprofen (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), midazolam (CYP3A), and fexofenadine (P-gp) with coffee/Coke (CYP1A2) on four occasions. They received the cocktail alone (session 1), and with the CYP inhibitors fluvoxamine and voriconazole (session 2) and quinidine (session 3). In session 4, subjects received the cocktail after a 7-day pretreatment with the inducer rifampicin. The concentrations of probes/metabolites were determined in DBS and plasma using a single liquid chromatography–tandem mass spectrometry method. The pharmacokinetic profiles of the drugs were comparable in DBS and plasma. Important modulation of CYP and P-gp activities was observed in the presence of inhibitors and the inducer. Minimally invasive one- and three-point (at 2, 3, and 6 h) DBS-sampling methods were found to reliably reflect CYP and P-gp activities at each session. Nature Publishing Group 2014-09 2014-05-07 /pmc/articles/PMC4151019/ /pubmed/24722393 http://dx.doi.org/10.1038/clpt.2014.83 Text en Copyright © 2014 American Society for Clinical Pharmacology and Therapeutics http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Articles Bosilkovska, M Samer, C F Déglon, J Rebsamen, M Staub, C Dayer, P Walder, B Desmeules, J A Daali, Y Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots |
title | Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots |
title_full | Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots |
title_fullStr | Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots |
title_full_unstemmed | Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots |
title_short | Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots |
title_sort | geneva cocktail for cytochrome p450 and p-glycoprotein activity assessment using dried blood spots |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151019/ https://www.ncbi.nlm.nih.gov/pubmed/24722393 http://dx.doi.org/10.1038/clpt.2014.83 |
work_keys_str_mv | AT bosilkovskam genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT samercf genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT deglonj genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT rebsamenm genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT staubc genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT dayerp genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT walderb genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT desmeulesja genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots AT daaliy genevacocktailforcytochromep450andpglycoproteinactivityassessmentusingdriedbloodspots |